Analysts remain positive on Teva

The quarterly and annual financials of Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) released last Wednesday sent the company’s share price tumbling 13.9% on the day, and the slide continued on the following days as well….

Continue Reading

Comments

Leave a Reply